In a statement, PTC's chief executive, Matthew Klein, said the company had decided to pull the filing for Translarna (ataluren) as a treatment for nonsense mutation DMD after the FDA said it was ...
PTC Therapeutics, Inc. PTCT closed lower on Thursday following the company’s decision to withdraw its New Drug Application for Translarna after receiving feedback from the U.S. Food and Drug ...
Barchart on MSN
PTC stock outlook: Is Wall Street bullish or bearish?
Boston, Massachusetts-based PTC Inc. (PTC) provides software solutions and services globally that aid manufacturing companies in designing, operating, and managing products. With a market cap. of $18.
Investing.com -- PTC Inc (NASDAQ:PTC) stock fell 3.8% on Thursday after Google announced a major upgrade to its Gemini 3 Deep Think AI system, potentially challenging PTC’s position in the engineering ...
Zacks Investment Research on MSN
PTC Therapeutics (PTCT) expected to beat earnings estimates: What to know ahead of Q4 release
Wall Street expects a year-over-year increase in earnings on higher revenues when PTC Therapeutics (PTCT) reports results for ...
Product design software company PTC (NASDAQ:PTC) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with ...
PTC Inc. (PTC) delivered earnings and revenue surprises of +20.47% and +7.43%, respectively, for the quarter ended December ...
Product design software company PTC (NASDAQ:PTC) reported Q4 CY2025 results exceeding the market’s revenue expectations, with ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results